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Objective: To evaluate three image acquisition presets
for four-dimensional cone beam CT (CBCT) to identify an
optimal preset for lung tumour image quality while
minimizing dose and acquisition time.
Methods: Nine patients undergoing radical conventionally
fractionated radiotherapy for lung cancer had verification
CBCTs acquired using three presets: Preset 1 on Day 1 (11mGy
dose, 240s acquisition time), Preset 2 on Day 2 (9mGy dose,
133s acquisition time) and Preset 3 onDay 3 (9mGydose, 67s
acquisition time). The clarity of the tumour and other thoracic
structures, and the acceptability of the match, were retro-
spectively graded by visual grading analysis (VGA). Logistic
regression was used to identify the most appropriate preset
and any factors that might influence the result.
Results: Presets 1 and 2 met a clinical requirement of 75% of
structures to be rated “Clear” or above and 75% of matches
to be rated “Acceptable” or above. Clarity is significantly
affected by preset, patient, observer and structure. Match
acceptability is significantly affected by preset.
Conclusion: The application of VGA in this initial study
enabled a provisional selection of an optimal preset
(Preset 2) to be made.
Advances in knowledge: This was the first application of
VGA to the investigation of presets for CBCT.
INTRODUCTION
Moving structures (for example, lung tumours) can produce
artefacts and blurring that affect the accuracy of radiotherapy
veriﬁcation when using cone beam CT (CBCT).1,2 This led
to the development of four-dimensional CBCT (4D-CBCT)
where the series of projections are binned into different
phases of the breathing cycle which minimizes blurring.2 The
disadvantage is that the amount of data for image recon-
struction of each phase is reduced compared with conven-
tional three-dimensional CBCT (3D-CBCT). This leads to
streak artefacts and some loss of image quality.3
One solution is to slow down the gantry speed so that more
frames can be acquired.3 However, this leads to additional
dose to the patient, given that the dose per frame is the
same and the frame acquisition rate is constant. The longer
acquisition time reduces patient throughput and increases
the possibility that the patient may move.3,4
Alternative reconstruction algorithms to reduce streaking,
different gantry speeds or multiple rotations have been
studied with the aim of reducing dose and image acquisi-
tion time.3,5–10 These used quantitative methods for image
quality to compare techniques using phantoms or very
small numbers of patients (up to four).
Rit et al1 used accuracy of veriﬁcation (measurement of
patient-positioning errors) alongside quantitative methods in
a study involving patients, by combining a different re-
construction algorithm with two gantry speeds. The use of
accuracy allows the effect of real patient factors to be included
(principally tumour movement and location, and patient size).
Dose optimization within radiotherapy departments is
encouraged, and any image taken should be of sufﬁcient
quality for the purpose.11 Investigating image quality by
observer methods can complement quantitative methods
(for example, signal-to-noise ratio or contrast) and accu-
racy of veriﬁcation and can also incorporate the effect of
real patient factors. Visual grading analysis (VGA) involves
observers reviewing the images and rating the visibility (or
clarity) of a given list of structures and rating the overall
image acceptability.12,13 Structures are also identiﬁed when ver-
iﬁcation is carried out in radiotherapy, therefore VGA is a good
ﬁt for a study of veriﬁcation image quality. The alternative
observer-based method (receiver operating characteristics) tends
to be used to determine the accuracy of a diagnostic technique.12
A hybrid between the two methods is also available.14
VGA has been used in radiotherapy veriﬁcation by Sweeney et al15
when observers were asked to match 4D-CBCT scans using both
four-dimensional (4D) and three-dimensional matching methods.
They also found that 4D-CBCTwas more accurate than 3D-CBCT
because of improved visualization of small tumours with large
motion amplitudes and of tumours close to the diaphragm.
Five other radiotherapy studies used VGA to compare portal
ﬁlm with electronic portal imaging.16–20 Three later studies also
used VGA but compared other imaging methods.21–23 These
included replacing the standard target in the linear accelerator
by an aluminium target,21 a modiﬁed computed radiography
(CR) cassette22 and using two different methods of processing
CR images.23 In all the above studies (which covered a range of
body sites including the lung), observers were asked to rate
certain aspects of the images such as ease of veriﬁcation, visi-
bility of selected anatomical structures, comparison of one
modality with the other or preference for one modality over the
other. One study also included accuracy of veriﬁcation.18
In the study reported here, an investigation of image quality and
acceptability of 4D-CBCT for radiotherapy was carried out using
VGA to evaluate the effect of three different presets with varying
acquisition times and dose.
METHODS AND MATERIALS
The Elekta (Crawley, UK)-recommended preset in XVI software
v. 4.5 (Elekta) for the acquisition of 4D-CBCT (known here as
Preset 1) takes 4min to acquire and has a high nominal [volume
CT dose index (CTDIvol)] dose. CTDIvol is a standardized
method of measuring dose using a cylindrical phantom.24 Two
additional presets had been created: Preset 3 (identical to the
Elekta-recommended 3D-CBCT preset for lung treatment veri-
ﬁcation) and Preset 2 (designed to have the same dose as Preset
3 and to have a faster delivery than Preset 1) (Table 1). The likely
reduction in image quality due to undersampling from the lower
number of projections could render Presets 2 and 3 unsuitable
for veriﬁcation. Any increase in noise due to reduction in mAs
is likely to be less signiﬁcant.7,25 All three presets use 120-kVp
X-rays and are delivered over 200° of rotation (start angle 340°
and stop angle 180°) with a 27-cm diameter ﬁeld of view.
Approval for this study as a service evaluation was given by the
Trust’s Research and Development Department. Veriﬁcation
images for this study came from ten patients receiving radical
conventionally fractionated radiotherapy between August 2013
Table 1. Presets 1, 2 and 3 compared with a three-dimensional (3D) cone beam CT preset. Preset 1 and the 3D preset have Elekta
(Crawley, UK)-recommended values
Preset parameter Preset 1 (Elekta) Preset 2 Preset 3 3D Preset (lung) (Elekta)
Gantry speed (degreesmin21) 50 90 180 180
Delivery time 4min 2min and 13 s 1min and 7 s 1min and 7 s
Approximate number of frames (projections) 1320 700 360 360
mA/frame 20 20 25 25
ms/frame 16 25 40 40
mAs/frame 0.32 0.5 1 1
Total mAs 422.4 350 360 360
Nominal (CTDIvol measured) dose (mGy) 11 9 9 9
Dose (CT dose index scaled by mAs) (mGy) 10.56 8.75 9 9
CTDIvol, volume CT dose index.
Figure 1. Example screen shots for Patient 10 from a single respiratory phase (Phase 1): (a) Preset 1, (b) Preset 2 and (c) Preset 3.
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and July 2014. These patients had all consented to the use of
their images for research purposes as part of their consent to
radiotherapy treatment. They were a convenience sample, and
VGA was carried out retrospectively. One patient (Patient 6) was
excluded from the study because his tumour had been excised,
leaving nine patients in the study. All (except Patient 1) were
treated supine with arms above their heads, supported by
a standard lung board and with a knee rest. Patient 1 was treated
prone with head and arms supported by a prone pillow, with a
pad beneath his ankles, since a stable supine position had not
been achievable without collision with the gantry. All had 4D-
CT planning scans acquired (Phillips Brilliance big bore with
2-mm slice thickness). The patients had been unable to comply
with the Assisted Breathing Coordinator™ (Elekta) normally
used for radical treatment of patients with lung cancer.26
4D-CBCT images were acquired on the ﬁrst three factions using
Presets 1, 2 and 3 at Fractions 1, 2 and 3, respectively. Example
screen shots are shown in Figure 1.
Four volunteer observers were recruited from the pool of
radiographers with advanced competencies in veriﬁcation for
stereotactic lung radiotherapy (which includes the use of 4D-
CBCT). The other radiographers would require training in the
use of the software. Each observer reviewed all 27 images. For
each patient, the images were reviewed from Preset 3 ﬁrst, then
from Preset 2 and ﬁnally from Preset 1. In this order, observers
would not have prior knowledge of what they might see in the
poorer quality images. Blinding the observers was not possible,
and the lack of blinding could be a confounding factor.
The observers independently rated the clarity of the edges of the
tumour and of certain other thoracic structures.12,16–23 Each of
the six edges of the tumour were rated since some edges may be
clearer to see than others. The other thoracic structures were
those commonly used as surrogate structures when reviewing
images. The list was based on Yin et al20 and was chosen because
it was a comprehensive list without being too onerous. These
structures were the vertebrae, chest wall and ribs, clavicle, apex
of lung, diaphragm, and trachea, bronchi and carina (the last
three structures were combined together).
The clarity scale was chosen to have only four steps (“very clear”,
“clear”, “unclear” and “not visible”) to avoid observers choosing
the middle option.27 Other VGA studies in radiotherapy have
used an odd number of steps. A ﬁfth option (“not imaged”) was
included for the thoracic structures since some would not ap-
pear in all of the images.
Next, the observers performed a 4D dual registration match
(XVI software v. 4.5) (bone match to a large volume, then 4D
grey match to a volume around the tumour) and recorded the
translation and rotation patient-positioning errors and rated the
acceptability of the match. The acceptability scale was based on
the European standard for CT image quality13 with changes in
wording (“very acceptable”, “acceptable”, “acceptable with res-
ervations” and “not acceptable”).
Guidelines were given with examples of images with very clear,
clear and unclear tumours, and deﬁnitions of acceptability were
added. The basis of these deﬁnitions is given below:
Very acceptable: The observer encountered no difﬁculties with
the automatic match.
Acceptable: The observer experienced some uncertainty or made
a small manual adjustment (1 or 2mm).
Acceptable with reservations: The observer used the automatic
bone match alone or carried out a full manual match because
the grey match failed, or there was excessive rotation, or the
observer wanted to discuss the match with a colleague.
Unacceptable: The observer would decline to treat based on this
image or wanted a clinician to review the image.
The location of tumour, size of tumour, amplitude of tumour
motion and size of the patient were also recorded since they may
Table 2. Details of the nine patients included in this study with data from their four-dimensional CT planning scans. Patient 6 was
excluded
Patient Stages Lung Lobe
Maximum
separation (cm) Volume of
GTV (cm3)
Maximum dimensions of
GTV (cm)
Ant./
post.
Left/
right
Ant./
post.
Sup./
inf.
Left/
right
1 T3N0M0 Right Lower 28.4 32.6 150 7.2 7.0 8.1
2 T3N1M0 Right Upper 28.7 44.5 35 5.8 4.8 4.3
3 T2aN1M0 Right Hilum 20.5 31.6 116 7.3 8.8 6.4
4 T1aN2M0 Left Upper 23.3 36.1 6 2.4 1.8 2.7
5 T3N2M0 Left Lower 20.8 37.0 13 3.0 4.8 3.3
7 T3N0M0 Left Upper 16.7 40.2 44 5.9 3.4 5.6
8 T4N2M0 Left Hilum 24.2 39.3 388 11.2 12.0 14.1
9 T3N1M1b Left Upper 26.9 45.4 96 7.3 7.4 6.6
10 T2N1M0 Right Lower 22.6 34.5 51 7.3 6.2 3.9
ant., anterior; GTV, gross tumour volume; inf., inferior; post., posterior; sup., superior.
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affect clarity or acceptability.1,2,28 The patient separation (anterior/
posterior and left/right), tumour volume and overall tumour size
(gross tumour volume, at end exhale) were measured from the
planning scans in the treatment planning system. Separation was
taken to be the maximum separation on a CT slice containing the
planning target volume. The 4D-CBCT software measures the
peak-to-peak amplitude of the breathing motion. One factor that
can affect image quality is the breathing rate.7 The user does not
have access to this information without additional equipment or
processing of the raw data, therefore it was not included.
The data from the observers were carefully checked to identify
errors of completeness in accordance with best practice.29 There
were nine instances of missing clarity values, which were “missing
completely at random” since they were overlooked.29 They were
generally replaced by the mode of the values chosen by the same
observer for the other structures from the same scan. (A measure of
central tendency is an acceptable method of replacing a missing
value.29) The choices made by the other observers were also con-
sidered since, in two cases, “not imaged” was an appropriate entry.
The analysis was carried out in SPSS® v. 22 (IBM Corp., New York,
NY; formerly SPSS Inc., Chicago, IL) using binary logistic re-
gression by converting the scales to binary values (the divisions
were made between “clear” and “unclear”, and between “accept-
able” and “acceptable with reservations”). “Not imaged” was treated
as missing data for the analysis. Logistic regression was chosen
because the clarity and acceptability data were non-parametric.30
Ordinal logistic regression could have been used31 but dis-
tinguishing between, say, “unclear” and “not visible” did not
make clinical sense in this study. To estimate model goodness of
ﬁt, Nagelkerke’s pseudo R2 (which has a potential range from
0 to 1, where 1 indicates a perfect model) was calculated.32
There was a clinical requirement (set by a consultant clinical
oncologist) that a preset should get acceptability ratings of
“acceptable” or higher and clarity ratings of “clear” or higher on
at least 75% of images for it to be clinically useful. This was
based on the requirement that an image should have sufﬁcient
quality for its purpose.11
RESULTS
The data on patient size, tumour size and tumour location are
presented in Table 2. Only Patient 9 was obese (body mass index
.30), and none were severely obese. Scatter plots of patient-
positioning errors and box plots of patient breathing motion are
shown in Figures 2 and 3. The VGA results from the observers
are summarized in Figures 4 and 5.
Clarity was tested against preset, patient, observer, structure,
lung and lobe of lung, and against patient size, size of tumour
and breathing motion. Each variable was tested individually, and
those that were signiﬁcant (p, 0.05) were placed together in
a backwards stepwise binary logistic regression. The ﬁnal model
is shown in Table 3. Variables were removed from the ﬁnal model if
grossly not signiﬁcant (p.0.1). Two terms that had been signiﬁ-
cant in an individual analysis but were removed from the ﬁnal
model (because their signiﬁcance had increased to .0.1) were
breathing motion amplitude in the superior/inferior direction
Figure 3. Tumour motion due to breathing by patient from all
images (left/right motion is ,2mm for all patients and
therefore is not included here).
Figure 2. Positioning errors by patient and subdivided by preset from all images and all observers: (a) translational errors and
(b) rotation errors. Where the observers did not agree on an error value for a particular image, more than one data point with the
same symbol occurs.
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[p50.002, odds ratio (OR)56.912] and breathing motion am-
plitude in the anterior/posterior direction (p5 0.022, OR51.442).
Acceptability was tested against preset, patient, observer, lung
and lobe of lung, and against patient size, size of tumour,
breathing motion and the magnitude of the positioning errors.
The same logistic regression method was used. Acceptability
could not be tested against clarity because clarity was assessed 13
times in each scan while acceptability was assessed once. The
result showing the ﬁnal model is shown in Table 4. Two terms
that had been signiﬁcant individually were removed from the
ﬁnal model; they were anterior/posterior dimension of the gross
tumour volume (p5 0.03, OR5 1.262) and the pitch rotation
positioning error (p5 0.049, OR5 1.246).
Both clarity and acceptability could not be tested by patient in the
ﬁnal analyses because the degrees of freedom were reduced. The
individual logistic regression results are shown in Tables 5 and 6.
Preset 3 only achieves 44% for clarity (ignoring the “not im-
aged” results) and 58% for acceptability, and therefore fails the
clinical requirement (Figures 4a and 5a). Preset 2 has 78% for
clarity and 86% for acceptability, whereas Preset 1 has 89% for
clarity and 97% for acceptability, therefore both presets meet the
clinical requirement.
DISCUSSION
Clarity and acceptability are both signiﬁcantly affected by preset
(Tables 3 and 4). Preset 1 has the best results, whereas Preset 3
has the least acceptable (lower OR values than either Preset 1 or
2). Preset 2 has the same dose as Preset 3 but has better image
quality because more projections are taken thereby reducing
undersampling.7
The patient has a statistically signiﬁcant effect on clarity
(Table 5, Figure 4b). Those patients who had a statistically
signiﬁcant effect (Patients 5, 7 and 8) all had tumours that
were close to other structures so that the edges were unclear
(Figure 4c). These three patients were responsible for most
of the “unclear” and “not visible” results for Presets 1 and 2.
In clinical practice, images such as these would be reviewed
by a clinician and radiographer. Patient 3 is also just statistically
signiﬁcant (p5 0.048), and this is due to poor visibility of tumour
edges with Preset 3, which had been commented on by the
Figure 5. Results for acceptability: (a) by preset and (b) by patient and subdivided by preset.
Figure 4. Results for clarity: (a) by preset, (b) by patient and subdivided by preset and (c) by patient and subdivided by preset (data
from tumour edges only).
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observers. The OR values show that these patients have lower
clarity than Patient 1. The Nagelkerke’s R2 value is low (0.075),
suggesting that the patients did not inﬂuence clarity strongly
(other factors may have more inﬂuence).30
Acceptability is not dependent upon patients but Patient 4 has
a signiﬁcantly poorer acceptability than Patient 1 (Table 6,
Figure 5b), and this is due to the high translation and rotation
positioning errors seen in the images for this patient (Figure 2).
These errors were independent of preset since they occurred on
all 3 days. Patient 4 also had a separate nodal planning target
volume which made veriﬁcation decision-making difﬁcult. The
positioning errors for this patient are probably responsible for
the signiﬁcance of the anterior/posterior translation error in the
ﬁnal model for acceptability (Table 4). SPSS was unable to ﬁnd
a solution for one of the test statistics leading to the calculation
of the goodness of ﬁt parameters.
Despite providing examples of images where the tumours were
“very clear”, “clear” and “unclear” in the instructions, there
was still signiﬁcant variation between observers for clarity
(Table 3). Observer 1 was signiﬁcantly more likely to select
“clear” or “very clear” than the other three (their ORs are
similar and ,1). The variation existed despite providing
sample images, but it is likely that this variation cannot be
completely removed. This agrees with the ﬁndings of other
studies.16,20,23 Deﬁning terms for acceptability did reduce
variation between observers.
Table 3. Final logistic regression model for clarity. Nagelkerke’s R250.446
Variable Significance (p) OR 95% CI for OR
Observer 1 <0.001
Observer 2 <0.001 0.145 0.087–0.240
Observer 3 <0.001 0.084 0.050–0.140
Observer 4 <0.001 0.201 0.121–0.334
Preset 1 <0.001
Preset 2 <0.001 0.382 0.250–0.585
Preset 3 <0.001 0.052 0.034–0.080
Structures
Sup. tumour edge <0.001
Inf. tumour edge 0.226 0.656 0.332–1.297
Left tumour edge 0.722 1.135 0.565–2.277
Right tumour edge 0.011 0.416 0.211–0.819
Ant. tumour edge 0.384 0.738 0.373–1.463
Post. tumour edge 0.226 0.656 0.332–1.297
Vertebral bodies 0.281 1.476 0.727–2.997
Heart 0.001 3.835 1.680–8.755
Chest wall and ribs 0.069 1.957 0.949–4.032
Clavicle 0.003 4.628 1.688–12.685
Trachea, carina and bronchi <0.001 5.959 2.478–14.327
Lung apex 0.001 6.771 2.250–20.380
Diaphragm 0.979 0.989 0.430–2.273
Lung
Right lung <0.001 1.892 1.353–2.648
Max. a/p separation <0.001 1.100 1.052–1.149
ant., anterior; CI, confidence interval; inf., inferior; Max. a/p separation, maximum anterior/posterior separation of the patient; OR, odds ratio; post.,
posterior; sup., superior.
p-values ,0.05 are shown in bold.
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The signiﬁcant structures (Table 3) for clarity are mostly those
with many instances of “not imaged”, so their signiﬁcance
probably is artiﬁcially raised and the low numbers are often
below or close to the requirement for 10 events for binary lo-
gistic regression.29 However in certain patients (particularly,
Patients 5, 7 and 8), some tumour edges were difﬁcult to dis-
tinguish from other adjacent structures which probably accounts
for the signiﬁcant result and low OR for the right edge of tu-
mour. All the instances of “acceptable with reservations” for
Presets 1 and 2 were associated with Patients 5 and 8, with
Patient 4 (due to high positioning errors).
The patient-dependent variables that were thought to affect
clarity and acceptability were generally not signiﬁcant and not
included in the ﬁnal analyses. Further study of more patients
would be required to investigate the effect of patient-dependent
variables. Right lung had a higher OR than left lung and was
signiﬁcant for both clarity and acceptability. Patients 5, 7 and 8
(with tumours adjacent to other structures) and Patient 4 (with
the large positioning errors) had left lung tumours, thereby re-
ducing clarity and acceptability for the patients with left lung
tumours. The maximum anterior/posterior patient separation
was a signiﬁcant term in the ﬁnal model for clarity but with an
OR .1. This suggests that clarity improves as the patient sep-
aration increases, which does not make clinical sense.28 Patients
5 and 7 (with low clarity levels) had small anterior/posterior
separations which may be one explanation for this result.
The Nagelkerke’s R2 values suggest that the terms in the models
are reasonable predictors of acceptability (0.503) and clarity
(0.446).30 The events per variable for acceptability is low at 7 (a
total of 21 “not acceptable” or “acceptable with reservations”
results and 3 variables in the ﬁnal model) while the ideal is 10 or
more. This could be improved by more patients or more
observers. This suggests that the ﬁnal model has some un-
certainty. The events per variable for clarity is 72 (361 “not
visible” or “unclear” results and 5 variables in the ﬁnal model)
which is acceptable and suggests a more reliable model.
The logistic regression models show that clarity varies with preset
and observer and that acceptability varies with preset. The presence
of other signiﬁcant terms in the models seems to depend more on
whether the tumour is attached/not attached to other structures
than the actual values of the terms (e.g. left or right lung).
A prospective study, where the presets could be applied in
a random order, may avoid any bias from possible patient
anxiety. Patients could also be selected to reduce variability, for
example, by excluding those with unusual immobilization, nodal
disease or with tumours attached to other structures. Other
studies have excluded patient groups such as those with
breathing motion ,5mm1 or those with nodal disease.4 The
effect of breathing rate could also be investigated if an external
method of measuring could be added.
CONCLUSION
An initial recommendation of Preset 2 could be made, with Preset
1 in reserve for when image quality is insufﬁcient. By choosing
Preset 2, the nominal dose is reduced by 18% and the acquisition
time is reduced by almost half compared with Preset 1. In certain
circumstances, Preset 1 could be preferred. This may include
imaging a tumour where the edges are hard to distinguish.
Another circumstance might include where the patient has a large
separation (larger than the patients in this study), but there was
insufﬁcient evidence to state this deﬁnitely.
Table 5. Individual logistic regression model for clarity by
patient. Nagelkerke’s R250.075
Patient Significance (p) OR 95% CI for OR
1 <0.001
2 0.125 0.633 0.352–1.136
3 0.048 0.55 0.304–0.995
4 0.697 0.882 0.468–1.662
5 <0.001 0.218 0.122–0.388
7 <0.001 0.316 0.176–0.568
8 <0.001 0.358 0.202–0.633
9 0.582 0.841 0.455–1.556
10 0.788 0.918 0.490–1.718
CI, confidence interval; OR, odds ratio.
p-values ,0.05 are shown in bold.
Table 4. Final logistic regression model for acceptability. Nagelkerke’s R250.503
Variable Significance (p) OR 95% CI for OR
Preset 1 0.001
Preset 2 0.242 0.250 0.024–2.552
Preset 3 0.002 0.030 0.003–0.273
a/p error 0.007 0.076 0.012–0.488
Lung
Right lung 0.002 12.264 2.523–57.615
a/p error, anterior/posterior translation positioning error; CI, confidence interval; OR, odds ratio.
p-values ,0.05 are shown in bold.
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Preset 3 is not recommended since the clarity of the structures
and acceptability of the matches was not of sufﬁcient quality to
be used for veriﬁcation.
Future work could include investigating patient breathing mo-
tion from both 4D-CT and 4D-CBCT to predict patients who
would beneﬁt most from 4D-CBCT. Comparing accuracy of
three dimensional and 4D-CBCT matches may also contribute
to the selection of patients.
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